03-3622. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Human Respiratory Pathogens: Bacterial (Part A).

    Date: March 18, 2003.

    Time: 8:30 a.m. to 6 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.

    Contact Person: Eugene R. Baizman, Ph.D., Scientific Review Administrator, NIH/NIAID/DEA, Scientific Review Program, Room 2209, 6700B Rockledge Drive, Bethesda, MD 20892-7616. 301-496-2550. eb237e@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Human Respiratory Pathogens: Viral (Part B).

    Date: March 19, 2003.

    Time: 8:30 a.m. to 6 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.

    Contact Person: Eugene R. Baizman, Ph.D., Scientific Review Administrator, NIH/NIAID/DEA, Scientific Review Program, Room 2209, 6700B Rockledge Drive, Bethesda, MD 20892-7616. 301-496-2550. eb237e@nih.gov.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856 Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Dated: February 6, 2003.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 03-3622 Filed 2-13-03; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
3/18/2003
Published:
02/14/2003
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
03-3622
Dates:
March 18, 2003.
Pages:
7571-7571 (1 pages)
PDF File:
03-3622.pdf